PROSTATE-SPECIFIC ANTIGEN (PSA) - ANVISA Registration 80022230298

Access comprehensive regulatory information for PROSTATE-SPECIFIC ANTIGEN (PSA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80022230298 and manufactured by GOLD ANALISA DIAGNOSTICA LTDA. The registration is held by GOLD ANALISA DIAGNOSTICA LTDA with validity until Jul 21, 2035.

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS INC., ABBOTT IRELAND DIAGNOSTIC DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.